Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Tax Rate (2016 - 2025)

Ani Pharmaceuticals' Tax Rate history spans 14 years, with the latest figure at 12.56% for Q4 2025.

  • For Q4 2025, Tax Rate fell 1280.0% year-over-year to 12.56%; the TTM value through Dec 2025 reached 18.22%, up 161.0%, while the annual FY2025 figure was 18.22%, 161.0% up from the prior year.
  • Tax Rate for Q4 2025 was 12.56% at Ani Pharmaceuticals, down from 21.3% in the prior quarter.
  • Across five years, Tax Rate topped out at 37.15% in Q3 2021 and bottomed at 21.86% in Q4 2023.
  • The 5-year median for Tax Rate is 21.77% (2021), against an average of 16.99%.
  • The largest annual shift saw Tax Rate surged 63527bps in 2021 before it plummeted -4769bps in 2023.
  • A 5-year view of Tax Rate shows it stood at 21.77% in 2021, then grew by 19bps to 25.84% in 2022, then tumbled by -185bps to 21.86% in 2023, then soared by 216bps to 25.36% in 2024, then crashed by -50bps to 12.56% in 2025.
  • Per Business Quant, the three most recent readings for ANIP's Tax Rate are 12.56% (Q4 2025), 21.3% (Q3 2025), and 18.95% (Q2 2025).